This HTML5 document contains 155 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n10http://dx.doi.org/10.2147/

Statements

Subject Item
wd:Q35683784
rdf:type
wikibase:Item
schema:description
artigo científico artikel ilmiah naučni članak scientific article published on 24 August 2010 2010年论文 научная статья articolo scientifico artikulong pang-agham 2010年論文 מאמר מדעי bài báo khoa học 2010年论文 article scientifique wetenschappelijk artikel wissenschaftlicher Artikel 2010年論文 мақолаи илмӣ 2010년 논문 vitskapeleg artikkel vedecký článok artigo científico 2010 nî lūn-bûn tudományos cikk 2010年论文 научни чланак บทความทางวิทยาศาสตร์ scienca artikolo mokslinis straipsnis article científic scientific article published on 24 August 2010 artículo científico publicado en 2010 επιστημονικό άρθρο vědecký článek tieteellinen artikkeli სამეცნიერო სტატია article scientific 2010年論文 articol științific 2010年论文 наукова стаття, опублікована в серпні 2010 vitenskapelig artikkel artigo científico գիտական հոդված 2010年論文 научна статия 2010年の論文 2010年论文 artikull shkencor vetenskaplig artikel artículu científicu espublizáu en 2010 scientific article published on 24 August 2010 мақолаи илмӣ artykuł naukowy 2010年論文 مقالة علمية نشرت في 24 أغسطس 2010 bilimsel makale 2010年论文 ২৪ আগস্ট ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак teaduslik artikkel videnskabelig artikel
p:P577
wds:Q35683784-4351E200-037C-47F1-8D4A-8D632CB0AE9E
wdt:P577
2010-08-24T00:00:00Z
p:P2860
wds:Q35683784-04B4F3AD-8DBA-43D3-970D-1E62B88CD339 wds:Q35683784-14A0A48D-1FEC-4B10-8B39-35655AF3B96A wds:Q35683784-19C1539D-EADE-407D-8ECA-49173A4B88B5 wds:Q35683784-1DC0D4DB-125B-421C-94EB-17A1D9D1DDC1 wds:Q35683784-215910D3-80CC-4929-A0EA-CB96F1A92AE6 wds:Q35683784-320CB702-C6AA-4E1C-8682-1BBE2DCC55DD wds:Q35683784-4ECCF251-94F5-4B3A-A48E-CA578473D3D5 wds:Q35683784-53AECD00-A56A-48A2-90AE-5E9D24979C94 wds:Q35683784-34C2583E-8E26-452B-BE89-CEDBAD50C914 wds:Q35683784-557EDCDA-A215-4A26-B942-51DBC1D75E56 wds:Q35683784-35B9B49E-6324-4448-AC7C-629ABCAF478F wds:Q35683784-56F58CED-3290-4A7D-85D0-C73E993E2A26 wds:Q35683784-3F074C5F-50C1-4D25-9ED1-1E06DE2BFADA wds:Q35683784-5977004A-5174-40DC-A7A8-1ADAE469F6BB wds:Q35683784-4049E8A4-04E3-4E3F-B37C-2A5151CB02E5 wds:Q35683784-6A068071-B360-4BA5-AB2B-0465836395E4 wds:Q35683784-46D27C3A-879A-4863-86F2-2FDB54624C9A wds:Q35683784-4E306B52-AF2E-414D-85A4-2CC96D8C5F87 wds:Q35683784-7FB9B5FD-B995-4597-99E4-E950A4DF8225 wds:Q35683784-9B06F74B-7C48-4342-9D53-296A60AA1F05 wds:Q35683784-BF047210-CCA2-4FCB-8971-B452E657A6B5 wds:Q35683784-BFAC7A3D-0DD6-489B-BFE6-CF84E9947747 wds:Q35683784-C132C6D5-C714-46D5-97FB-67C41FE6CD9E wds:Q35683784-D6E86A20-07B1-44AE-9551-D73863CD9945 wds:Q35683784-D886025B-6151-4C52-B7FE-8B7E83F110FD wds:Q35683784-F5A45039-2615-45CD-B591-41DD986FEF89
wdt:P2860
wd:Q41630608 wd:Q34019841 wd:Q82612998 wd:Q71130170 wd:Q33915553 wd:Q40773682 wd:Q34062526 wd:Q37007907 wd:Q43826723 wd:Q34317472 wd:Q66840036 wd:Q36645174 wd:Q44567400 wd:Q50866890 wd:Q28174681 wd:Q34432153 wd:Q28630834 wd:Q35761512 wd:Q67459828 wd:Q34255146 wd:Q37506359 wd:Q45345619 wd:Q73288257 wd:Q39647378 wd:Q50958759 wd:Q34132269
p:P2093
wds:Q35683784-0904DF2C-C3D0-4945-B20A-B296B16199A3 wds:Q35683784-C47512E2-6F3D-41DA-8A59-164CB445C8B0 wds:Q35683784-6A7A1C12-3547-406D-B4F9-3D535F4704D3
wdt:P2093
Timothy Craig Michael Lunn Carah Santos
rdfs:label
Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety
skos:prefLabel
Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety
schema:name
Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety
p:P1476
wds:Q35683784-88469337-C808-4E35-AC84-54651965D743
wdt:P1476
Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety
p:P304
wds:Q35683784-33349A3A-E8EE-4964-9281-6CBB66D4109E
wdt:P304
163-170
p:P31
wds:Q35683784-29E822F9-45D2-4C1B-9511-F08E145ECA43
wdt:P31
wd:Q13442814
p:P921
wds:Q35683784-E21F1CEB-4BC5-4C43-9E21-2B2E8567A3FD
wdt:P921
wd:Q2096745
p:P698
wds:Q35683784-84C70CA2-4B37-47D5-9D6F-90403A4B969B
wdtn:P698
n12:22282695
wdt:P698
22282695
p:P1433
wds:Q35683784-90A0A259-41CC-4942-A927-9292F5B70D76
wdt:P1433
wd:Q15817438
p:P478
wds:Q35683784-81826595-3C82-45C8-8730-899A086A607E
wdt:P478
1
p:P356
wds:Q35683784-6B770DFA-81DA-48F4-B7D2-12A7F567F0EF
wdtn:P356
n10:JBM.S9576
wdt:P356
10.2147/JBM.S9576
p:P275
wds:Q35683784-22e3bc2e-daae-4b7b-b0fe-7994cb30639f
p:P6216
wds:Q35683784-73b5a4e8-049a-4e28-bc88-93434c10721a
wdt:P275
wd:Q18810331
wdt:P6216
wd:Q50423863
p:P932
wds:Q35683784-EA9A8AC1-6A59-4B68-A19B-4FD1A4FDC3AB
wdt:P932
3262319